← Back
$RIGL All transactions

RIGEL PHARMACEUTICALS INC

M

$ Value

$0

Shares

2,846

Price

$0

Filed

Dec 29

Insider

Name

Schorno Dean L

Title

EVP & Chief Financial Officer

CIK

0001509688

Roles

Officer

Transaction Details

Transaction Date

2025-12-22

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

17,153

Footnotes

These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. | Includes 500 shares of common stock acquired under the Issuer's stock purchase plan. | The shares of common stock subject to the option vested in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019, subject to the reporting person's continuous service to the Issuer through each such period. | The shares of common stock subject to the option vested in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the Issuer through each such period. | The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer through each such period.

Filing Info

Accession No.

0000905148-25-004492

Form Type

4

Issuer CIK

0001034842

Schorno Dean L's History

Date Ticker Type Value
2026-02-17 RIGL A $0
2026-02-10 RIGL F $123K
2026-02-02 RIGL F $198K
2025-12-22 RIGL M $40K
2025-12-22 RIGL M $69K
2025-12-22 RIGL M $31K
2025-12-22 RIGL M $0
2025-12-22 RIGL M $0
2025-12-22 RIGL M $0
2025-09-15 RIGL A $0

Other Insiders at RIGL (90d)

Insider Bought Sold Last
MOOS WALTER H $145K 2026-02-20
RODRIGUEZ RAUL R
CEO, President
2026-02-17
MILLER MICHAEL PATRICK 2026-02-01
Schorno Dean L
EVP & Chief Financial Officer
2026-02-17
Furey Raymond J.
EVP, GC, CCO & Corp Sec
2026-02-17
Santos David A
EVP, Chief Commercial Officer
2026-02-17
Rojkjaer Lisa
EVP, Chief Medical Officer
2026-02-17